We are live on ! Find out more
SIM

Sentry Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 25.43%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+25.43%
3 Year Est. Return
+103.36%
5 Year Est. Return
+144.61%
10 Year Est. Return
+516.47%
AUM
$209M
AUM Growth
-$56.1M
Cap. Flow
-$48.6M
Cap. Flow %
-23.31%
Top 10 Hldgs %
30.62%
Holding
525
New
28
Increased
14
Reduced
461
Closed
21

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$608K
2
LRCX icon
Lam Research
LRCX
+$511K
3
LOW icon
Lowe's Companies
LOW
+$501K
4
C icon
Citigroup
C
+$491K
5
CI icon
Cigna
CI
+$490K

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Healthcare 13.4%
3 Financials 12.35%
4 Consumer Discretionary 10.85%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
76
Elevance Health
ELV
$89.5B
$593K 0.28%
1,363
-330
-19% -$150K
TJX icon
77
TJX Companies
TJX
$135B
$593K 0.28%
6,674
-1,523
-19% -$134K
ADP icon
78
Automatic Data Processing
ADP
$109B
$576K 0.28%
2,393
-486
-17% -$118K
MDLZ icon
79
Mondelez International
MDLZ
$79.6B
$548K 0.26%
7,900
-1,736
-18% -$125K
MRSH
80
Marsh
MRSH
$84.4B
$546K 0.26%
2,868
-651
-18% -$125K
GILD icon
81
Gilead Sciences
GILD
$183B
$542K 0.26%
7,235
-1,560
-18% -$120K
SYK icon
82
Stryker
SYK
$109B
$536K 0.26%
1,962
-421
-18% -$121K
LMT icon
83
Lockheed Martin
LMT
$124B
$530K 0.25%
1,296
-314
-20% -$139K
BLK icon
84
Blackrock
BLK
$161B
$527K 0.25%
815
-250
-23% -$175K
CVS icon
85
CVS Health
CVS
$117B
$521K 0.25%
7,466
-1,617
-18% -$115K
VRTX icon
86
Vertex Pharmaceuticals
VRTX
$130B
$520K 0.25%
1,496
-321
-18% -$112K
ADI icon
87
Analog Devices
ADI
$175B
$510K 0.24%
2,911
-509
-15% -$93.9K
REGN icon
88
Regeneron Pharmaceuticals
REGN
$79.7B
$510K 0.24%
620
-144
-19% -$113K
AXP icon
89
American Express
AXP
$211B
$504K 0.24%
3,378
-746
-18% -$122K
CB icon
90
Chubb
CB
$132B
$494K 0.24%
2,373
-575
-20% -$116K
ETN icon
91
Eaton
ETN
$155B
$494K 0.24%
2,314
-305
-12% -$65.8K
CI icon
92
Cigna
CI
$74.1B
$492K 0.24%
+1,719
New +$490K
LRCX icon
93
Lam Research
LRCX
$337B
$488K 0.23%
+7,780
New +$511K
SLB icon
94
SLB Ltd
SLB
$77.6B
$482K 0.23%
8,266
-1,106
-12% -$64.1K
SCHW
95
Charles Schwab
SCHW
$182B
$475K 0.23%
8,645
-2,118
-20% -$128K
PGR icon
96
Progressive
PGR
$126B
$473K 0.23%
3,399
-722
-18% -$95K
ZTS icon
97
Zoetis
ZTS
$30.2B
$465K 0.22%
2,673
-612
-19% -$111K
C icon
98
Citigroup
C
$223B
$460K 0.22%
+11,181
New +$491K
BSX icon
99
Boston Scientific
BSX
$63.6B
$449K 0.22%
8,504
-1,623
-16% -$85.1K
AMT icon
100
American Tower
AMT
$82.2B
$445K 0.21%
2,705
-580
-18% -$106K

Similar funds

Sentry Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sentry Investment Management held 525 positions worth $209M, down 21% from $265M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sentry Investment Management withdrew a net $48.6M in Q3 2023, closing 21 positions and reducing 461 holdings. Its most notable exit was Chart Industries, an estimated $620K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sentry Investment Management opened a new position in AT&T worth $623K.

  • Sentry Investment Management's largest Q3 2023 buy was AT&T: 41,478 shares worth $623K.
  • Sentry Investment Management added most to Lowe's Companies in Q3 2023, an estimated $501K increase.
  • Sentry Investment Management's biggest Q3 2023 reduction was Alphabet (Google) Class A, cutting an estimated $1.61M.
  • Sentry Investment Management fully exited Chart Industries in Q3 2023, selling an estimated $620K.
  • Sentry Investment Management's ten largest holdings make up 31% of its $209M portfolio in Q3 2023.
  • Sentry Investment Management opened 28 new positions and closed 21 in Q3 2023.
  • Sentry Investment Management's portfolio value fell 21% quarter-over-quarter to $209M.

Based on Sentry Investment Management's 13F filing for Q3 2023, filed 3 Nov 2023.